Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies - Concepedia

Concepedia

Publication | Open Access

Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies

DOI Full Paper Access

111

Citations

19

References

2017

Year

Paulina Nowakowska, A Romański, Nicole Miller, Marcus Odendahl, Halvard Bönig, Congcong Zhang, Erhard Seifried, Winfried S. Wels, Torsten Tonn

Cancer Immunology Immunotherapy

Cell TherapyMalignant Blood DisorderImmunologyBlood CellErbb2-positive MalignanciesImmunotherapyMedicineCell BiologyCar-expressing Nk-92 Cells

References

	Year	Citations

Page 1

Page 1